Global and United States Lanoxin API Market Insights, Forecast to 2027

Digoxin is a cardiac glycoside extracted from the leaves of the foxglove plant Digitalis lanata. Although the properties of digitalis extracts have been known since the dark ages, their cardiac effects were discovered by the Scottish doctor William Withering in 1776. According to the history, during the treatment of one of his patients, who had a severe heart condition to which no treatment was available at that time. As a last resource, the patient went to a local gypsy, who gave him a secret plant extract, which improved his condition considerably. Intrigued by the fact, Dr. Withering met the gypsy, who revealed that the active ingredient of her potion was an extract of a foxglove plant. Currently, digoxin is on the World Health Organization’s List of Essential Medicines.

Market Analysis and Insights: Global and United States Lanoxin API Market
This report focuses on global and United States Lanoxin API market.
In 2020, the global Lanoxin API market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In United States the Lanoxin API market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Lanoxin API Scope and Market Size
Lanoxin API market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Lanoxin API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Lanoxin API market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
Purity: ≥98%
Purity: <98%

Segment by Application
Tablet Product
Injection Product

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
C2 Pharma
Alkaloids Corporation
Vital Labs
Alchem